Post by ProPharma Academy

💊 ProPharma Academy Daily Dose | # 21 📅 Daily Dose: India's Biologics Moment 🇮🇳🧬 📰 The News: On July 14, 2026, Bengaluru-based OneSource Specialty Pharma announced a strategic manufacturing partnership with Germany's Formycon AG, one of Europe's leading independent biosimilar developers. OneSource will provide both drug substance and drug product manufacturing from its biologics facility in Bengaluru, supporting Formycon's biosimilar programs for global markets. Formycon already has three biosimilars commercialised globally, with four more in development — including biosimilars targeting pembrolizumab and dupilumab. 🌍💉 🔬 Concept Decoded: This deal is a great lesson in what makes biologics manufacturing so different from generic tablets. Biosimilars aren't simple chemical copies — they require managing living cell lines, maintaining extreme systemic purity, and navigating complex biological approval processes. Two terms every pharma student should master here: Drug Substance (DS) — the active biological ingredient that provides the therapeutic effect — and Drug Product (DP) — the final finished injectable formulation supplied to patients after filling, packaging, and quality testing. Owning both ends of that chain is what separates a commodity CDMO from a true strategic manufacturing partner. 🧫➡️💊 🚀 Career Takeaway: India's CDMOs with integrated biologics capabilities and globally-approved facilities are increasingly attractive to multinational pharma companies looking to outsource development and commercial manufacturing cost-efficiently. OneSource sees this as proof that India is uniquely positioned to be a global hub for developing and manufacturing world-class biologics. For students eyeing careers in biologics manufacturing, CMC, or bioprocess engineering — this is exactly the kind of "Made in India, trusted globally" trend to watch and mention in interviews. 📈🎯 #PharmaGraduates #JobSeeking #EntryLevelJobs #PharmaCareers #CareerGuidance #SkillDevelopment #propharma-academy #Pharmacovigilance #ClinicalDataManagement #CDMO #SimpleeLearnifySeries #CraftingPharmaLeaders #PharmaIndustry #PharmaStudents